Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CA Clinics, formerly known as Cannabis Access Clinics, is a leading network of medical clinics in Australia and the United Kingdom specializing in medicinal cannabis treatments. The company provides patient consultations and facilitates the regulatory approval process for accessing cannabis-based medicines through frameworks like Australia's Therapeutic Goods Administration (TGA) Special Access Scheme. Their clinical team focuses on treating chronic conditions such as neuropathic pain, epilepsy, and treatment-resistant anxiety when conventional therapies have failed. By integrating clinical research with patient care, CA Clinics aims to improve patient outcomes and contribute to the growing body of evidence for cannabinoid therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannabis Access Clinics.